NUCOR CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NUCOR CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $25.07B | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.49B | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | $7.08B | Feb 27, 2025 |
| FY2024 | Sep 28, 2024 | $7.44B | Feb 27, 2025 |
| FY2024 | Jun 29, 2024 | $8.08B | Feb 27, 2025 |
| FY2024 | Mar 30, 2024 | $8.14B | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $7.70B | Feb 27, 2025 |
| FY2024 | Sep 30, 2023 | $8.78B | Feb 27, 2025 |
| FY2024 | Jul 1, 2023 | $9.52B | Feb 27, 2025 |
| FY2024 | Apr 1, 2023 | $8.71B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $8.72B | Feb 27, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $5.09B | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $5.17B | Feb 28, 2018 |
| FY2017 | Jul 1, 2017 | $5.17B | Feb 28, 2018 |
| FY2017 | Apr 1, 2017 | $4.82B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $3.96B | Feb 28, 2018 |
| FY2017 | Oct 1, 2016 | $4.29B | Feb 28, 2018 |
| FY2017 | Jul 2, 2016 | $4.25B | Feb 28, 2018 |
| FY2017 | Apr 2, 2016 | $3.72B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $3.46B | Feb 28, 2017 |
| FY2016 | Oct 3, 2015 | $4.23B | Feb 28, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $627.00M | Feb 27, 2025 |
| FY2024 | Sep 28, 2024 | $758.00M | Feb 27, 2025 |
| FY2024 | Jun 29, 2024 | $1.19B | Feb 27, 2025 |
| FY2024 | Mar 30, 2024 | $1.52B | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $1.39B | Feb 27, 2025 |
| FY2024 | Sep 30, 2023 | $1.92B | Feb 27, 2025 |
| FY2024 | Jul 1, 2023 | $2.50B | Feb 27, 2025 |
| FY2024 | Apr 1, 2023 | $2.00B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.10B | Feb 27, 2024 |
| FY2023 | Oct 1, 2022 | $2.84B | Feb 27, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | $287.00M | Feb 27, 2025 |
| FY2024 | Sep 28, 2024 | $250.00M | Feb 27, 2025 |
| FY2024 | Jun 29, 2024 | $645.00M | Feb 27, 2025 |
| FY2024 | Mar 30, 2024 | $845.00M | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $785.00M | Feb 27, 2025 |
| FY2024 | Sep 30, 2023 | $1.14B | Feb 27, 2025 |
| FY2024 | Jul 1, 2023 | $1.46B | Feb 27, 2025 |
| FY2024 | Apr 1, 2023 | $1.14B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.26B | Feb 27, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.22B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.59B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.00B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.71B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $615.04M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $711.25M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $860.72M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $687.53M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $596.76M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.23B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.98B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $7.11B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $10.07B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $6.23B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.70B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.81B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $2.39B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.06B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.75B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.42B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.21B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.95B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.62B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.54B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.48B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $982.53M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $448.56M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $604.84M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.10B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $33.94B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $35.34B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $32.48B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $25.82B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $20.13B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $18.34B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $17.92B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $15.84B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $15.22B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.98B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $12.52B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $13.22B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $12.91B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $11.22B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $8.89B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $7.55B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $7.72B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $6.76B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $6.97B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.94B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $20.29B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $20.94B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $18.41B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $14.02B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $10.79B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $10.36B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $9.79B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $8.74B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $7.88B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.30B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.29B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.97B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $3.92B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.83B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.23B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.20B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $2.18B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $2.20B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $2.05B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.50B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $30.27B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $28.76B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $24.75B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $17.67B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $11.34B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $11.12B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $10.34B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $8.46B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $7.63B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.56B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.38B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.28B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.36B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.64B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.53B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.40B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $949.10M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.05B | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $4.36B | Feb 28, 2017 |
| FY2016 | Dec 31, 2015 | $4.36B | Feb 28, 2017 |
| FY2015 | Dec 31, 2014 | $4.38B | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $4.38B | Feb 27, 2015 |
| FY2013 | Dec 31, 2012 | $3.63B | Feb 28, 2014 |
| FY2012 | Dec 31, 2011 | $4.28B | Feb 28, 2013 |
| FY2011 | Dec 31, 2010 | $4.28B | Feb 28, 2012 |
| FY2010 | Dec 31, 2009 | $3.09B | Feb 28, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 27, 2025 |
| FY2024 | Sep 28, 2024 | 1 | Feb 27, 2025 |
| FY2024 | Jun 29, 2024 | 2 | Feb 27, 2025 |
| FY2024 | Mar 30, 2024 | 3 | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | 3 | Feb 27, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Feb 27, 2025 |
| FY2024 | Jul 1, 2023 | 5 | Feb 27, 2025 |
| FY2024 | Apr 1, 2023 | 4 | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 4 | Feb 27, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 27, 2025 |
| FY2024 | Sep 28, 2024 | 1 | Feb 27, 2025 |
| FY2024 | Jun 29, 2024 | 2 | Feb 27, 2025 |
| FY2024 | Mar 30, 2024 | 3 | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | 3 | Feb 27, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Feb 27, 2025 |
| FY2024 | Jul 1, 2023 | 5 | Feb 27, 2025 |
| FY2024 | Apr 1, 2023 | 4 | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 4 | Feb 27, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $512.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $522.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $515.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $534.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $483.47M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $491.66M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $492.06M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $485.38M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $485.32M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $481.08M | Feb 28, 2019 |